sustained-release | Media Room

Tagged sustained-release

Press Release Jul 1, 2020

LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery

OcuRing™ is a novel drug delivery platform for cataract surgery with potential to eliminate the need for postoperative topical eye drops. $3M DoD award will fund IND-enabling toxicology and manufacturing activities. LayerBio plans to develop OcuRing™ products for multiple cataract surgery-related indications.

Press Release Mar 6, 2017

Vaxess Technologies Receives Grants Totaling $6 Million to Develop Microneedle Vaccines for Polio, Measles, Rubella

Grant Funding Will Support Preclinical Development of Two Vaccines Using Vaxess's MIMIX™ Delivery Platform

First
Prev

Next
Last